NPY promoted the growth of exocrine pancreatic carcinoma cells [202], and the peptide was released from human insulinomas, leading to a high serum NPY level, which returned to a standard level after surgical resection of the tumors [203]. Here, NPY is linked to exocrine pancreatic carcinoma.